[KHIDI-BioHub] Prevenotics has been selected as a recipient of the "2023 Bio-Medical Startup Domestic and International Market Expansion Capacity Enhancement" program organized by the Korea Health Industry Development Institute (KHIDI) and BioHub, with the aim of enhancing the market competitiveness of bio-medical startup companies. As part of this support, Prevenotics will receive tailored consulting and services necessary for overseas market expansion. This opportunity follows their previous selection in June for the University of Utah's Acceleration Program and is expected to be a valuable process in increasing the success potential of Prevenotics' overseas business. 

[KHIDI-바이오허브] 프리베노틱스는 한국보건산업진흥원과 바이오허브가 바이오ᆞ의료 분야 창업기업을 대상으로 시장 경쟁력 향상을 목표로 주최한 ‘2023년  바이오·의료 창업기업 국내·외 시장진출 역량강화’ 지원대상으로 선정되어 해외 시장진출에 필요한 맞춤형 컨설팅 및 서비스 등을 받게 됩니다. 이는 지난 6월 유타대학교 Acceleration program선정에 이어 프리베노틱스의 해외사업의 성공가능성을 높이는 유용한 과정이 될 것입니다.